Cdx1, a dispensable homeobox gene for gut development with limited effect in intestinal cancer
The homeobox gene Cdx1 is involved in anteroposterior patterning in embryos and its expression selectively persists in the intestinal epithelium throughout life. In human colon cancers, Cdx1 is overexpressed in few cases and lost in the majority of adenocarcinomas. We used mouse models of gain and l...
Saved in:
Published in | Oncogene Vol. 27; no. 32; pp. 4497 - 4502 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
24.07.2008
Nature Publishing Group Nature Publishing Group [1987-....] |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The homeobox gene
Cdx1
is involved in anteroposterior patterning in embryos and its expression selectively persists in the intestinal epithelium throughout life. In human colon cancers,
Cdx1
is overexpressed in few cases and lost in the majority of adenocarcinomas. We used mouse models of gain and loss-of-function to investigate the role of
Cdx1
in intestinal development and cancers. Transgenic mice overexpressing
Cdx1
and knockout mice exhibited a morphologically normal intestine. Cell proliferation, specification into the four differentiated lineages and migration along the crypt-villus axis were unchanged compared to wild-type mice. Changing
Cdx1
caused an inverse and dose-dependent modification of the expression of the paralogous gene
Cdx2
, indicating that
Cdx1
fine-tunes
Cdx2
activity. Transgenenic and knockout mice failed to spontaneously develop tumours. Overexpressing
Cdx1
was without incidence on the frequency of intestinal tumours induced chemically by azoxymethane treatment or genetically in Apc
Δ14/+
mice. However, it augmented the severity of the tumours in Apc
Δ14/+
mice. Inversely, the loss-of-function of
Cdx1
in knockout mice was without incidence on the growth of tumours induced by azoxymethane. We conclude that
Cdx1
is dispensable for intestinal development and that its overexpression could increase malignancy in early stages of tumourigenesis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2008.78 |